Decrease in the plasma von Willebrand factor concentration following glucose ingestion: The role of insulin sensitivity

Metabolism: Clinical and Experimental

Volumn 50, Issue 12, 2001, Pages 1452-1456

  Von Kanel R ^a   Nelesen, R A ^a   Le, D T ^a   Ziegler, M G ^a   Dimsdale, J E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIGEN; ANTIHYPERTENSIVE AGENT; CATECHOLAMINE; GLUCOSE; INSULIN; NORADRENALIN; VON WILLEBRAND FACTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE INTAKE; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; REST; SCREENING TEST; STANDARD; SYSTOLIC BLOOD PRESSURE; TIME;

EID: 0035657006     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.26742     Document Type: Article

References (35)

1. Von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10-year follow up of survivors of acute myocardial infarction
2. Factor VIII, ABO blood group and the incidence of ischaemic heart disease
3. Von Willebrand factor: Structure and function
4. Von Willebrand factor and its relevance to cardiovascular disorders
5. Abnormalities of coagulation and fibrinolysis in insulin resistance
6. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM
7. Insulin resistance and cardiovascular disease
8. Von Willebrand factor and endothelial damage in essential hypertension
9. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes
10. Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old men
11. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia
12. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study
13. Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome
14. The metabolic syndrome - A neuroendocrine disorder?
15. Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes
16. The postprandial state and risk of cardiovascular disease
17. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo
18. Changes of plasma coagulation and fibrinolysis in response to mental stress
19. Validation of the insulin sensitivity index (ISI(0,120)): Comparison with other measures
20. 1983 Metropolitan height and weight tables
21. Insulin release and peripheral sensitivity at the oral glucose tolerance test
22. Factor VIII related antigen: An improved enzyme immunoassay
23. Determination of free and total insulin and C-peptide in insulin-treated diabetics
24. A more sensitive and specific radioenzymatic assay for catecholamines
25. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
26. Insulin resistance and the regulation of vascular tone: Is insulin a vasodilator?
27. Von Willebrand factor in thrombotic thrombocytopenic purpura
28. Clearance of normal and type 2A von Willebrand factor in the rat
29. Von Willebrand factor in diabetic angiopathy
30. The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects
31. Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules
32. Circadian variation in endothelial cell function, red blood cell deformability and dehydrothromboxane B2 in healthy volunteers
33. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease
34. Deficient noradrenergic response to oral glucose in hypertensives
35. The role of "diabetogenic" hormones on carbohydrate and lipid metabolism following oral glucose loading in insulin dependent diabetics: Effects of acute hormone administration